Gastric Cancer with a Very High Serum CA 19-9 Level
| Autor: | Mineko Higuchi, Minoru Matsuda, Atsushi Nagase, Hidenori Yamaguchi, Hiroyuki Furukawa, Takako Kawakami, Kazuya Kato, Kazuhiko Onodea, Masahiko Taniguchi |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
medicine.medical_specialty
business.industry Stomach Gastroenterology CA 15-3 Cancer Adenocarcinoma medicine.disease medicine.anatomical_structure CA 19-9 Internal medicine Pancreatic cancer medicine lcsh:Diseases of the digestive system. Gastroenterology CA19-9 Published: April 2011 Lymph lcsh:RC799-869 Gastric cancer business Antrum |
| Zdroj: | Case Reports in Gastroenterology Case Reports in Gastroenterology, Vol 5, Iss 1, Pp 258-261 (2011) |
| ISSN: | 1662-0631 |
| DOI: | 10.1159/000327984 |
| Popis: | Carbohydrate antigen 19-9 (CA 19-9) is a sensitive marker for pancreatic and hepatobiliary malignancies. The highest frequency of elevated serum CA 19-9 levels is found among patients with pancreatic cancer. CA 19-9 has recently been demonstrated to be a marker of digestive tract malignancies. We report the case of a patient with a gastric cancer and a very high serum CA 19-9 level. During laparotomy, a large mass was found in the antrum. A distal gastrectomy with D2 dissection of the lymph nodes was performed. Histological examination, including immunohistochemistry, revealed an adenocarcinoma of the stomach producing CA 19-9. To the best of our knowledge, no patient with an extremely high serum CA 19-9 level resulting from a gastric adenocarcinoma has been reported previously. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|